Questions that still need to be addressed are how mutant neutrophil elastase proteins shape the “fertile ground” for acquisition of CSF3R mutations and how CSF3 treatment contributes to reshaping this into the cellular state in which elevated inflammatory responses are induced and tolerated and RUNX1 mutations can be acquired, resulting in progression to AML. The gene discussed is CSF3; the disease is acute myeloid leukemia.